ResearchAndMarkets.com has added two separate reports: one projects the global artificial intelligence in life sciences market to grow from $5.69 billion in 2026 to $73.05 billion by 2040 at a 20% compound annual growth rate, while the other forecasts the broader artificial intelligence market to rise from $601.93 billion in 2026 to $3.63 trillion by 2033. The life-sciences study focuses on drug discovery, precision medicine, diagnostics and clinical research, whereas the broader report examines enterprise generative AI, infrastructure, software, operations and supply-chain applications. North America is identified as a leading region in both studies, while Asia Pacific is expected to record the fastest growth in the broader market. Both reports cite adoption barriers including data governance, regulatory requirements, infrastructure or energy constraints, interoperability and shortages of specialized talent.